Refractory Childhood Malignant Solid Neoplasm
2 clinical trials · Condition
◉ Watch Refractory Childhood Malignant Solid Neoplasm
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma (NCT06620302) | Children's Oncology Group | 2025-06-12 |
| Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling (NCT05857969) | Florida International University | 2023-02-22 |
Track Refractory Childhood Malignant Solid Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.